StockData
RAPPNasdaqPharmaceutical PreparationsFiscal year ends December 31

Rapport Therapeutics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$28.60+1.03 (+3.74%)

Close on Oct 19, 2026

Market cap
$1.36B
P/E (TTM)
–
Dividend yield
–

SEC filings

33 of Rapport Therapeutics's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Current report8-KOct 20, 2026Oct 20, 2026SEC EDGAR
Quarterly report10-QJun 30, 2026Aug 5, 2026SEC EDGAR
Current report8-KAug 5, 2026Aug 5, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 10, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 7, 2026SEC EDGAR
Current report8-KMay 7, 2026May 7, 2026SEC EDGAR
Proxy statementDEF 14AJun 10, 2026Apr 23, 2026SEC EDGAR
Current report8-KApr 21, 2026Apr 21, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 10, 2026SEC EDGAR
Current report8-KMar 10, 2026Mar 10, 2026SEC EDGAR
Current report8-KJan 7, 2026Jan 7, 2026SEC EDGAR
Current report8-KJan 7, 2026Jan 7, 2026SEC EDGAR
Quarterly report10-QSep 30, 2025Nov 6, 2025SEC EDGAR
Current report8-KNov 6, 2025Nov 6, 2025SEC EDGAR
Current report8-KSep 9, 2025Sep 10, 2025SEC EDGAR
Current report8-KSep 8, 2025Sep 8, 2025SEC EDGAR
Current report8-KSep 8, 2025Sep 8, 2025SEC EDGAR
Quarterly report10-QJun 30, 2025Aug 7, 2025SEC EDGAR
Current report8-KAug 7, 2025Aug 7, 2025SEC EDGAR
Current report8-KJun 17, 2025Jun 18, 2025SEC EDGAR
Current report8-KJun 2, 2025Jun 2, 2025SEC EDGAR
Quarterly report10-QMar 31, 2025May 8, 2025SEC EDGAR
Current report8-KMay 8, 2025May 8, 2025SEC EDGAR
Proxy statementDEF 14AJun 17, 2025Apr 24, 2025SEC EDGAR
Annual report10-KDec 31, 2024Mar 11, 2025SEC EDGAR
Current report8-KMar 11, 2025Mar 11, 2025SEC EDGAR
Current report8-KMar 3, 2025Mar 3, 2025SEC EDGAR
Current report8-KJan 9, 2025Jan 10, 2025SEC EDGAR
Quarterly report10-QSep 30, 2024Nov 7, 2024SEC EDGAR
Current report8-KNov 7, 2024Nov 7, 2024SEC EDGAR
Quarterly report10-QJun 30, 2024Aug 8, 2024SEC EDGAR
Current report8-KAug 8, 2024Aug 8, 2024SEC EDGAR
Current report8-KJun 6, 2024Jun 10, 2024SEC EDGAR